[The effect of total gnotobiological isolation and antimicrobial preparations on the survival of mice with acute radiation sickness]. 1991

L A Romanchuk, and V M Korshunov, and W Busch, and A A Ivanov, and N P Tarabrina

In experiments on 406 CBA mice the effect of antimicrobial preparations, used in combination with total gnotobiotic isolation, on the survival rate of totally irradiated animals was studied. The use of antimicrobial preparations was shown to considerably enhance the survival rate of these animals. Cyprofloxacin, a new preparation of the kinolone row, exhibited a good effect ensuring selective decontamination of the intestine. The use of cyprofloxacin prior to irradiation with the subsequent isolation of the animals in gnotobiotic chambers increased the survival rate of these animals by 2.7 times. But the maximum survival rate of irradiated mice was observed in those cases when antimicrobial preparations were used both before and after irradiation in combination with the total gnotobiotic isolation of the animals.

UI MeSH Term Description Entries
D007422 Intestines The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE. Intestine
D008808 Mice, Inbred CBA An inbred strain of mouse that is widely used in BIOMEDICAL RESEARCH. Mice, CBA,Mouse, CBA,Mouse, Inbred CBA,CBA Mice,CBA Mice, Inbred,CBA Mouse,CBA Mouse, Inbred,Inbred CBA Mice,Inbred CBA Mouse
D010356 Patient Isolation The segregation of patients with communicable or other diseases for a specified time. Isolation may be strict, in which movement and social contacts are limited; modified, where an effort to control specified aspects of care is made in order to prevent cross infection; or reverse, where the patient is secluded in a controlled or germ-free environment in order to protect him or her from cross infection. Home Isolation,Isolation, Home,Isolation, Patient,Negative Pressure Isolation,Negative Pressure Patient Isolation
D011833 Radiation Injuries, Experimental Experimentally produced harmful effects of ionizing or non-ionizing RADIATION in CHORDATA animals. Experimental Radiation Injuries,Injuries, Experimental Radiation,Experimental Radiation Injury,Radiation Injury, Experimental
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003666 Decontamination The removal of contaminating material, such as radioactive materials, biological materials, or CHEMICAL WARFARE AGENTS, from a person or object.
D005856 Germ-Free Life Animals not contaminated by or associated with any foreign organisms. Axenic Animals,Gnotobiotics,Germfree Life,Animal, Axenic,Animals, Axenic,Axenic Animal,Germ Free Life,Gnotobiotic,Life, Germ-Free,Life, Germfree
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

L A Romanchuk, and V M Korshunov, and W Busch, and A A Ivanov, and N P Tarabrina
January 2000, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
L A Romanchuk, and V M Korshunov, and W Busch, and A A Ivanov, and N P Tarabrina
May 1967, Meditsinskaia radiologiia,
L A Romanchuk, and V M Korshunov, and W Busch, and A A Ivanov, and N P Tarabrina
January 1968, Voprosy onkologii,
L A Romanchuk, and V M Korshunov, and W Busch, and A A Ivanov, and N P Tarabrina
January 1971, Radiobiologia, radiotherapia,
L A Romanchuk, and V M Korshunov, and W Busch, and A A Ivanov, and N P Tarabrina
January 1992, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
L A Romanchuk, and V M Korshunov, and W Busch, and A A Ivanov, and N P Tarabrina
November 1979, Khirurgiia,
L A Romanchuk, and V M Korshunov, and W Busch, and A A Ivanov, and N P Tarabrina
January 1984, Vestnik Akademii meditsinskikh nauk SSSR,
L A Romanchuk, and V M Korshunov, and W Busch, and A A Ivanov, and N P Tarabrina
January 1961, Farmakologiia i toksikologiia,
L A Romanchuk, and V M Korshunov, and W Busch, and A A Ivanov, and N P Tarabrina
February 1960, Meditsinskaia radiologiia,
L A Romanchuk, and V M Korshunov, and W Busch, and A A Ivanov, and N P Tarabrina
August 1968, Antibiotiki,
Copied contents to your clipboard!